March 10, 2020 / 3:18 PM / 25 days ago

BRIEF-Lee's Pharmaceutical Updates On Approval To Conduct Clinical Trial

March 10 (Reuters) - Lee’s Pharmaceutical Holdings Ltd :

* ALISKIREN COMBINED WITH NIFEDIPINE OBTAINED APPROVAL TO CONDUCT CLINICAL TRIAL ON HYPERTENSION PATIENT TREATMENT WITH COVID-19 PNEUMONIA

* APPROVAL FROM WEST CHINA HOSPITAL BIOMEDICAL ETHICS COMMITTEE OF SICHUAN UNIVERSITY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below